A mong patients referred for coronary angiography for suspected ischemia, women are found to have a lower prevalence of obstructive coronary artery disease (CAD) than men. However, the available evidence suggests that women who do have angiographic evidence of obstructive CAD have higher rates of adverse outcomes when compared with men. 1,2 It has been suggested that the adverse cardiovascular outcomes of women with CAD are mainly composed of readmission to hospital for angina symptoms; but this finding was based on the Women's Ischemia Syndrome Evaluation (WISE), which included only women. 2 It remains unknown whether hospital readmission for angina is a more significant component of the total adverse outcomes among women with obstructive CAD compared with men.
outcomes of patients who have undergone an angiographic evaluation for suspected ischemia in a wider spectrum of patients including those with stable angina or acute coronary syndrome (ACS). 1 However, the generalizability of these findings is narrow, given the evaluation was limited to only in-hospital mortality, and the study cohort was derived from hospitals, which voluntarily participated in the US National Cardiovascular Data Registry (NCDR).
Given the paucity of knowledge in this area of research, our aim was to extend these findings by examining, in a population-based cohort, the joint impact of sex and ethnicity on long-term adverse outcomes of stable angina and ACS patients with angiographic evidence of obstructive CAD. In particular, we were interested in determining whether hospital readmission because of angina is in fact a significant component of worse outcome in women compared with men, and if so, whether this difference varied by ethnicity and clinical presentation at the time of angiography.
Methods

Study Population and Data Sources
The study population included patients ≥20 years of age who underwent coronary angiography for ACS or stable angina between April 1, 2002, and December 31, 2008 , in British Columbia (BC), Canada, and had angiographic evidence of obstructive CAD, defined as ≥50% stenosis in any epicardial artery. Patients were identified using the population-based Cardiac Services BC (CSBC) registry, 7 which is a mandatory registry that prospectively captures detailed clinical and procedural data on all patients undergoing coronary angiography in BC. There are a total of 5 hospitals that perform coronary angiography in BC, all of which are included in the CSBC registry. For patients with multiple records of angiography during the study period, only the first one was included (ie, the index angiography).
Patients were excluded if sex or ethnicity was unknown or if they were not a BC resident (rehospitalization and mortality data were not available for non-BC residents). The remaining patients formed the final study cohort and were all followed for 2 years (follow-up date of last patient was December 31, 2010). A flowchart of the patient selection and study cohort is provided in Figure 1 .
Index angiography records of all patients were subsequently linked to the Discharge Abstract Database (DAD) 8 and the Death Registrations of BC Vital Statistics Agency, 9 using each individual's unique personal health number. The DAD was used to obtain information on any subsequent hospitalizations. We used the International Classification of Disease, 10th Revision codes to identify hospital readmissions for the outcome events: AMI (I21 and I22), heart failure (HF) (I50), cerebrovascular accident (I60, I61, I62, I63, and I64), and angina (I20.0, I24.0, I24.8, I24.9, R07.1, R07.3, and R07.4). It is important to note that these hospital readmissions, including those for angina, only included the most responsible diagnosis-the diagnosis responsible for either the greatest use of hospital resources or portion of the hospital stay. The BC Vital Statistics Agency data were used to obtain mortality data, both in-hospital and out of hospital, during the 2-year period.
The primary outcome of interest was a composite end point of all-cause mortality and hospital readmissions for nonfatal AMI, HF, cerebrovascular accident, or angina. Hospital readmissions for angina included unstable angina and acute chest pain as the most responsible diagnosis.
Comorbidities were identified using both the CSBC registry and the DAD. Other covariates of interest, including sex, age, clinical presentation at the time of angiography (stable angina or ACS), extent and severity of CAD, cardiac medication use at the time of angiography, as well as any subsequent revascularization (PCI or coronary artery bypass graft) procedure, were identified using the BC Cardiac Registry.
Because ethnicity is not documented in the CSBC registry, or the DAD, we used 2 validated surname analysis tools to categorize patients as having either South Asian (ancestors primarily from India, Pakistan, Bangladesh, and Sri Lanka) or Chinese (ancestors primarily from China, Taiwan, and Hong Kong) ethnicity. Ethnicity was assigned by CSBC using the Nam Pechan (South Asian) and Quan's List (Chinese) surname analysis programs, after which the dataset was stripped of all patient identifiers and sent to the research team. 10, 11 Compared with the gold standard of self-reported ethnicity, the Nam Pehchan algorithm has a sensitivity of 90% to 94% and specificity of 99.6% in identifying South Asian surnames 12 ; Quan's algorithm has a sensitivity of 78% and specificity of 99.7% in identifying Chinese surnames. 10 Any patient not identified as Chinese or South Asian, based on the abovementioned surname algorithms, was categorized as other. Based on the most recent Canadian census data available (2011), South Asians and Chinese are the 2 largest visible minority groups in BC, accounting for ≈7.2% and 10.1% of the total BC population, respectively. 13 All other visible minority groups who are neither Chinese nor South Asians collectively represent only ≈10% of the BC population. Therefore, the other group is mainly composed of white patients. Ethics approval was obtained from the local Research Ethics Board.
Statistical Analysis
Baseline demographic and clinical characteristics of women and men by ethnicity were examined using descriptive statistics for each of the initial clinical presentations (ACS and stable angina). Sex differences by ethnicity for each baseline characteristic were tested with a sex×ethnicity interaction in a logistic model.
The cumulative incidence rates for the composite end point were estimated for each sex and ethnicity group by initial clinical presentation using the Kaplan-Meier method and compared using the log-rank test. The Cox proportional-hazards model was used to estimate the unadjusted and adjusted hazard ratios and its 95% confidence intervals (CIs) of the composite end point for women versus men by ethnicity group among ACS and stable angina patients, respectively. The proportional-hazards assumption was assessed by the Schoenfeld residuals plots. The unadjusted model included sex, ethnicity, clinical presentation, and all 2-way interactions. Variables
WHAT IS KNOWN
• Women with acute coronary syndrome or stable angina and angiographic evidence of obstructive coronary artery disease have poorer outcomes than men, but the joint contribution of sex and ethnicity has not been examined.
WHAT THE STUDY ADDS
• Women with acute coronary syndrome or stable angina and angiographic evidence of obstructive coronary artery disease, irrespective of clinical presentation or ethnicity, are at significantly increased risk of adverse events within 2 years of angiography compared with men. • The most common adverse outcome, regardless of sex or initial clinical presentation, is hospital readmission for angina, which comprises 45% of adverse events occurring within 2 years of angiography. • Readmission for angina was observed for all sexethnic groups except for Chinese women whose adverse outcomes were driven by higher mortality rates. in the adjusted model were selected a priori based on clinical judgment. The factors of interest (sex, ethnicity, and clinical presentation) were kept in all models considered. Other candidate variables included in the final model were selected by using a backward selection approach; variables not significant at a significance level of 0.10 were removed from the model. The final adjusted model included age, extent of CAD, ejection fraction, urgency for angiography, diabetes mellitus, prior AMI, prior revascularization, renal disease, peripheral vascular disease, cerebrovascular accident, HF, chronic obstructive pulmonary disease, liver disease, cancer, and smoking. Revascularization (PCI or coronary artery bypass graft) during the index admission or after hospital discharge was modeled as a timedependent covariate. All 2-way and 3-way interactions among sex, ethnicity, and initial clinical presentation were assessed; the 3-way interaction was removed if not significant, but all 2-way interactions were kept in the models.
To investigate the contribution of each component within the composite end point, for the subgroup of patients experiencing an event, we estimated the proportion of each component for the sex and ethnicity groups. The odds of admission for angina as the first outcome event was examined in a logistic model for sex and ethnic groups by clinical presentation and we reported odds ratios (ORs) and 95% CI. In addition, we summarized the hospital length of stay (including any transfers to another acute care hospital) associated with each outcome component using medians and interquartile ranges by sex only because group sizes were <5 for some sex and ethnicity groups; a Wilcoxon rank-sum test was performed to test for sex differences for each component. Statistical analyses were performed using SAS software, version 9.4 (Cary, NC).
Results
Baseline Patient Characteristics at the Time of Angiography
Between April 1, 2002, and Dec 31, 2008, there were 49 787 patients who underwent an index coronary angiography for stable angina or ACS and were found to have obstructive CAD. A total of 231 (0.4%) were excluded for unknown sex or dual ethnicity (eg, Chinese and South Asian) or if they were not a BC resident. The remaining 49 556 patients formed the final study cohort. Overall, 25.6% of our study cohort were women, 9.5% were South Asians, 3.0% were Chinese, and 87.5% were in the other group, which is mainly composed of white patients. Furthermore, 65.9% of patients underwent angiography for ACS. Among the ACS patients, regardless of ethnicity, women were older and had higher prevalence of comorbid conditions, including hypertension, HF, and diabetes mellitus ( Table 1) . The prevalence of diabetes mellitus was particularly high among Chinese and South Asian women. Although sex differences in diabetes mellitus were observed among all ethnic groups, the magnitude of the difference was largest in Chinese women compared with that in Chinese men (P interaction =0.04). Similarly, modification of sex differences by ethnicity was also observed for the extent of CAD (presence of left main or 3-vessel disease; P interaction =0.04) and prior MI (P interaction =0.03) with Chinese women being more likely to have left main or 3-vessel disease and prior MI than Chinese men, whereas in the other ethnic groups women were less likely than men to have left main or 3-vessel disease and prior MI.
With the exception of the use of higher calcium channel blockers in women at presentation, there was no significant sex difference in the use of angiotensin-converting enzymes inhibitors, β-blockers, or statins at the time of index coronary angiography for the ACS group. As well, ethnicity did not modify the association between sex and medication use, including calcium channel blockers ( Table I in the Data  Supplement) .
Among stable angina patients, women were more likely to have hypertension, peripheral vascular disease, and HF (Table 2 ). However, no significant sex differences across ethnic groups were observed for any comorbid conditions in the stable angina cohort, with the exception of smoking status and prior MI. Similar to the ACS cohort, women were less likely to be smokers, and the sex differences in smoking varied by ethnicity (P interaction <0.001). In addition, although there was no sex difference in prior MI among Chinese and other group, South Asian men were more likely to have had a prior MI compared with South Asian women. Similar to the ACS group, there was no significant interaction between sex and ethnic groups for any of the medications at presentation ( Table  II in the Data Supplement).
Composite Outcome After Angiography
Overall, during the 2-year postangiogram period, the rates of the composite outcome were higher among patients with ACS than those with stable angina, regardless of sex or ethnicity ( Figure 2 ). Although the 3-way interaction among sex, ethnicity, and clinical presentation was not significant (P interaction =0.59), the sex difference varied with clinical presentation (P interaction =0.03); women had worse outcomes than men, with a larger sex difference observed among ACS patients (44-70% estimated higher risk of adverse outcomes in women than that in men in the ACS group and from 29-53% higher risk in women than that in men in the stable angina group over the different ethnicities). However, the magnitudes of the observed sex differences in the composite outcome did not vary by ethnicity (P interaction =0.64).
Even after adjusting for selected baseline demographic and clinical characteristics, women in every ethnic group still had higher rates of composite outcome than their male counterparts in both the ACS (a 32-59% estimated higher risk in women) and the stable angina cohorts (a 26-51% estimated higher risk in women). The hazard ratios and 95% CIs for women versus men are summarized in Table 3 . As in the unadjusted model, the 3-way interaction (P interaction =0.65), as well as the interaction between sex and ethnicity (P interaction =0.37), was not significant. Note that the significant sex-by-presentation interaction observed in the unadjusted model no longer remained after adjustment, indicating that the sex difference in the composite outcome did not vary by initial clinical presentation (P interaction =0.32).
Components of the Composite Outcome
As shown in Figure 2 , among all sex-ethnicity groups, women with ACS had the highest rates of the composite outcome, whereas Chinese men with stable angina had the lowest rate. Event rates among men presenting with ACS were similar, regardless of ethnicity, and were consistently lower than those among women with ACS.
Overall, angina readmission accounted for 44.6% of all adverse events (46.7% in women, 43.7% in men) and was more likely in women compared with men (OR [95% CI], 1.13 [1.04-1.22]). A closer examination of the contribution of angina readmission to the composite outcome in the stable angina group indicates at least 50% of the adverse events for women across ethnic groups, as well as South Asian men and other men were because of a hospital readmission for angina ( Figure 3 ). However, among Chinese men, angina comprises only 34.9% of the composite outcome. Women were more likely than men to be readmitted for angina among the other group (OR [95% CI], 1.35 [1.12-1.63]) but not among the South Asians or Chinese as shown in Figure 3 .
Although the contribution of angina readmission to the composite outcome as a whole was less among ACS than stable angina patients, it still was the main component, except in Chinese women ( Figure 3 ). Similar to the stable angina patients, women had a higher likelihood of angina readmission than men in the other group (OR [95% CI], 1.16 [1.05-1.27]). However, in the Chinese group, women were less likely than men to be readmitted for angina (0.43 [0.21-0.86]). In fact, the proportion of deaths exceeded that of angina readmission in Chinese women. Note that for South Asians, although the odds of angina admission did not differ between women and men, HF admission was high among South Asian women.
The length of hospital stay for readmission, as a proxy for the burden of rehospitalization on patients and the system, showed that cerebrovascular accident resulted in the longest hospital stay, followed by AMI and HF (Table 4 ). However, it is notable that 25% of patients readmitted for angina stayed in the hospital for >5 days among the ACS group and >7 days in the stable angina group.
Discussion
In this large, population-based cohort of stable angina and ACS patients with angiographic evidence of obstructive CAD, we found that women have poorer outcomes compared with men after coronary angiography, irrespective of ethnicity and initial clinical presentation. The observed sex differences persisted even after adjustment for differences in the baseline demographic and clinical characteristics. A key finding of our research is that the most common adverse outcome, regardless of sex or initial clinical presentation, is hospital readmission
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February 2016 for angina. This was observed for all sex-ethnic groups except for Chinese women whose adverse outcomes were driven by higher mortality rates. Our finding of excess risk of adverse events in women with obstructive CAD is consistent with reports from other studies, which have examined sex differences in the shortand long-term mortality outcomes of patients undergoing coronary angiography. A study by King et al 14 examined sex differences in long-term mortality of all patients who underwent coronary angiography between the years 1995 and 2000, based on the Alberta Provincial Project for Outcomes Assessment in Coronary Heart Disease (APPROACH) registry. Overall, women had higher mortality rates compared with men during the first year. When stratified by extent of CAD, the sex gap among patients with more severe CAD was wider than among patients with less severe CAD, particularly in the early period after angiography. A more recent study based on the Global Registry of Acute Coronary Events (GRACEs) also examined sex differences in adverse cardiac events (ie, death and rehospitalization) of ACS patients, after coronary angiography, between the years 1999 and 2006. Among patients with obstructive CAD, the risk of adverse event at 6 months after angiography was greater in women compared with that in men, even after adjusting for age and disease severity. Similar to these studies, our finding of more adverse outcomes in women with obstructive CAD, compared with men, could not be explained by the differences in baseline characteristics, ACS indicates acute coronary syndrome; CABG, coronary artery bypass graft; CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease; IQR, interquartile range; MI, myocardial infarction; and PCI, percutaneous coronary intervention.
comorbidities, or use of revascularization. The observed poorer outcomes among women could partially be related to the less aggressive use of cardiac procedures in women with CAD, although in our study adjustment for revascularization only slightly attenuated the higher risk of adverse events in women. In addition, we hypothesize that the differences in the vasculopathy between men and women could be one of the contributing factors to the poorer outcomes observed in women. Women have smaller, stiffer vessels with more fibrosis and microemboli than men, leading to greater angina burden and perhaps less revascularization and resulting in poorer adverse cardiac events. 15 Also, studies from the WISE suggest that many women, both with and without obstructive CAD, have abnormal coronary blood flow on invasive coronary reactivity testing, suggesting the presence of microvascular coronary dysfunction. Microvascular coronary dysfunction is associated with high frequency of angina and may contribute to the observed higher rates of hospitalizations for angina among women. 16 Finally, psychosocial risk factors, such as depression and poorer self-reported health status, which are more prevalent in women than in men are associated with worse outcomes 17, 18 and could explain some of the observed sex gap, but these factors are not routinely measured in clinical studies.
With regard to the joint contribution of sex and ethnicity on outcomes of CAD patients, little data are available. A study based on the American College of Cardiology's NCDR-CathPCI Registry did examine sex and ethnic differences for in-hospital mortality of patients referred for coronary angiography, in both ACS and stable angina cohorts, during the years 2000 to 2002. Shaw et al 1 found that overall women with obstructive CAD had higher odds of in-hospital mortality compared with men, regardless of clinical presentation. With respect to ethnicity, they did not observe any sex difference in mortality rates of black, Hispanic, Native American, and Asian patients, but white women, with ACS or stable angina, had a higher mortality rate than white men. However, based on 
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Circ Cardiovasc Qual Outcomes February 2016 our findings, we observed an excess risk of adverse outcomes in women with obstructive CAD compared with men not only among the other group, which is mainly composed of white patients, but also among Chinese and South Asian patients, regardless of the initial clinical presentation. To our knowledge, this is the first study to provide evidence of sex difference in adverse outcomes of these 2 visible minority groups, namely Chinese and South Asians. It is important to note that the magnitude of the observed sex difference did not vary by ethnicity and persisted even after adjustment for baseline and clinical differences in all ethnic groups. Our other notable finding was that readmission to hospital for angina was the most common adverse outcome in all patients, regardless of sex or initial clinical presentation. This was observed in all sex-ethnic groups, except Chinese women with ACS whose adverse outcome was mainly driven by higher mortality rates. Importantly, among stable angina patients, we observed a higher odds of hospital readmission for angina in all women, regardless of ethnicity, compared with their male counterparts, although only the difference in the other group reached was statistically significant. This is likely because of the smaller proportion of the Chinese and South Asians and the lower number of events, as is evident from the wider CIs of the ORs. Among ACS patients, other women again had significantly higher odds of hospital readmission for angina compared with other men, but among Chinese, the odds of admission for angina was significantly lower in women than in men. Among South Asians with ACS, the odds of angina admission did not differ between women and men, although HF admission was high among South Asian women.
Our finding that hospital readmission for angina was the most common adverse outcome in this obstructive CAD population has important implications in terms of impact on patients' quality of life and burden on the healthcare system. Previous studies have shown that persistent chest pain is associated with depression and diminished physical function, 19 both of which have been shown to also be independent predictors of increased morbidity and mortality. 20, 21 The overall Hospital readmissions were included only if the specified diagnoses were the most responsible diagnosis during the patient's hospital stay.
ACS indicates acute coronary syndrome; CI, confidence interval. *Composite outcome of all-cause death and hospital readmissions for nonfatal acute myocardial infarction (AMI), heart failure, cerebrovascular accident (CVA), and angina (including unstable angina and acute chest pain). †Adjustment for age, clinical presentation for coronary angiography, extent of coronary artery disease, ejection fraction, urgency for angiography, diabetes mellitus, prior AMI, prior revascularization, renal disease, peripheral vascular disease, CVA, heart failure, chronic obstructive pulmonary disease, liver disease, cancer, smoking, and revascularization as a time-varying covariate. All 2-way interactions among sex, ethnicity, and clinical presentation for coronary angiography were also included.
societal cost of angina hospitalizations is also not insignificant and has been estimated to be ≈494 billion pounds, in year 2000, based on a UK study. 22 Therefore, it is crucial to a better understanding of the reasons for the recurrent angina admissions, particularly among women. We speculate that evidencebased medication use after coronary angiography, which was not available for this cohort, was used to a lesser degree in women. Undertreatment of women has been reported in several previous studies. [23] [24] [25] Given the lower use of coronary revascularization in women with obstructive CAD, less use of evidence-based medications is plausible.
Another important finding that needs further examination is the observed higher mortality rates among Chinese women with ACS. This could be partially explained by their higher prevalence of left main or 3-vessel disease, as observed on their angiogram, and greater likelihood of prior MI. Other studies focused on examining ethnic variations in post-AMI or postrevascularization outcomes have also found that Chinese patients had the highest short-term mortality rates compared with South Asians or whites. It has been proposed that the higher mortality rates in Chinese patients may be because of delay in seeking treatment. 26 
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February 2016 because based on the available evidence, the common notion is that the Chinese population is at low risk of developing heart disease, such as AMI. This may lead to less awareness about the signs and symptoms of acute events in this population and lead to delay in seeking care or presenting to hospital. Although these findings and speculations are based on the overall Chinese population, it may be particularly relevant to Chinese women, given that women, in general, are less likely than men to consider themselves at risk of heart disease. Furthermore, there is some suggestion that Chinese patients are more likely to undergo emergent PCI, 26 after angiography, indicating that they may present with more severe disease and are, therefore, more likely to have poorer outcomes than other ethnic groups.
Our study has several limitations. In addition to the lack of information on pharmacological management after angiography, we cannot exclude the possibility of other unmeasured confounders. Although our study results are generalizable to populations undergoing coronary angiography for suspected CAD, there is a possibility of selection/referral bias, as evidence suggests that women are less likely to undergo coronary angiography than men.
We also acknowledge the potential of heterogeneity across or clustering within the 5 hospitals that perform coronary angiography in BC. Although we did not test for these issues, the angiography sites are all tertiary hospitals with large and similar procedural volumes and the same source of government funding. We therefore do not anticipate significant variations in terms of practice, hence heterogeneity in hazards across sites. It is also important to note that in the Canadian healthcare system, in a nonurgent setting, the referring family physician or cardiologist would provide follow-up care rather than the index hospital performing the angiography; therefore, any potential heterogeneity or clustering of patients among hospitals where the angiography was performed is unlikely to impact treatment and subsequent long-term outcomes.
Furthermore, we did not separate other ethnic groups such as Hispanics and blacks, who are also known to have higher cardiac risk, from our other group. Based on the 2011 Statistics Canada report on the distribution of ethnic backgrounds in BC, Hispanics and blacks each account for 0.8% of the total population compared with 10.1% Chinese and 7.0% South Asians (ie, these are the 2 largest ethnic minorities in BC). 27 Moreover, in addition to these groups comprising a small proportion of the ethnic composition in BC, which would most likely lead to inconclusive findings, we were limited to 2 available and validated surname algorithms for identifying the ethnicity, namely the Nam Pehchan (South Asian) and the Quan (Chinese) and had no other way of identifying those of Hispanic or black ethnicity.
Conclusions
Among adults with obstructive CAD, women, irrespective of clinical presentation or ethnicity, are at significantly increased risk of adverse events within 2 years of angiography compared with men. Hospital readmission for angina comprises 45% of adverse events occurring within 2 years of angiography. This places a significant burden on the healthcare system and reduces the quality of life of patients. Our findings highlight the need for targeted interventions to reduce the burden of angina in this population, as this presentation is clearly not benign.
